TD Asset Management
VIVO

TD Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

TD Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20,100
Closed -$356K – 1431
2016
Q4 		$356K Sell
20,100
-30,200
-60% -$531K ﹤0.01% 1265
2016
Q3 		$970K Buy
50,300
+19,900
+65% +$389K ﹤0.01% 1019
2016
Q2 		$593K Sell
30,400
-2,400
-7% -$47.1K ﹤0.01% 1070
2016
Q1 		$676K Sell
32,800
-1,400
-4% -$27.6K ﹤0.01% 1046
2015
Q4 		$702K Buy
34,200
+3,600
+12% +$69K ﹤0.01% 1023
2015
Q3 		$523K Buy
30,600
+900
+3% +$16.4K ﹤0.01% 1058
2015
Q2 		$554K Sell
29,700
-1,900
-6% -$35.2K ﹤0.01% 1087
2015
Q1 		$603K Buy
31,600
+1,700
+6% +$31.4K ﹤0.01% 1076
2014
Q4 		$492K Buy
29,900
+2,700
+10% +$46.3K ﹤0.01% 1102
2014
Q3 		$481K Buy
27,200
+4,100
+18% +$80.6K ﹤0.01% 1049
2014
Q2 		$477K Sell
23,100
-600
-3% -$12.3K ﹤0.01% 1048
2014
Q1 		$516K Buy
23,700
+1,600
+7% +$36.7K ﹤0.01% 1030
2013
Q4 		$586K Sell
22,100
-11,700
-35% -$288K ﹤0.01% 978
2013
Q3 		$799K Buy
33,800
+2,300
+7% +$53.7K ﹤0.01% 905
2013
Q2 		$677K Buy
+31,500
New +$679K ﹤0.01% 889

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

TD Asset Management's VIVO Position: Q1 2017 in Review

TD Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2017, closing a stake of 20,100 shares — an estimated $356K sold.

TD Asset Management first reported a position in VIVO in Q2 2013 and held it in 15 quarters. The position peaked at $970K in Q3 2016. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

  • TD Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2017 after selling out during the quarter.
  • TD Asset Management sold 20,100 Meridian Bioscience Inc shares in Q1 2017, an estimated $356K.
  • TD Asset Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 15 quarters.
  • TD Asset Management's Meridian Bioscience Inc position peaked at $970K in Q3 2016.
  • 165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on TD Asset Management's 13F filing for Q1 2017, filed 5 May 2017.